Prolonged use of the following drug has been implicated in the causation of suacute myelo-optic neuropathy (SMON):
**Core Concept**
Sudden myelo-optic neuropathy (SMON) is a rare but serious condition characterized by damage to the spinal cord and optic nerve, leading to symptoms such as vision loss and paralysis. This condition has been associated with the prolonged use of certain medications.
**Why the Correct Answer is Right**
The correct answer is related to the use of a medication that has been historically linked to SMON. The medication in question is a cholinesterase inhibitor, which is a class of drugs that increase the concentration of acetylcholine in the synaptic cleft. By inhibiting the enzyme acetylcholinesterase, these drugs prevent the breakdown of acetylcholine, leading to an accumulation of this neurotransmitter. This accumulation can cause an overstimulation of muscarinic and nicotinic receptors, resulting in various systemic effects, including the development of SMON.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because the medication in question is not a beta-blocker, which is a different class of drugs that is used to treat conditions such as hypertension and arrhythmias.
* **Option B:** This option is incorrect because the medication in question is not a statin, which is a class of drugs that is used to lower cholesterol levels and prevent cardiovascular disease.
* **Option C:** This option is incorrect because the medication in question is not a nonsteroidal anti-inflammatory drug (NSAID), which is a class of drugs that is used to treat pain and inflammation.
**Clinical Pearl / High-Yield Fact**
SMON is a rare but serious condition that can be caused by the prolonged use of certain medications. It is essential to monitor patients who are taking cholinesterase inhibitors for signs and symptoms of SMON, such as vision loss and paralysis.
**Correct Answer:** C. Chloroquine.